|
1
|
Tan JY, Augustinović M, Omar AM, Lourenzon VB, Krull N, Lopez X, Khin M, Shetye G, Nguyen D, Qader M, Nugent AC, Mpofu E, Williams C, Rodriguez J, Burdette JE, Cho S, Franzblau SG, Eustáquio AS, Zhang Q, Murphy BT. Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club. ACS OMEGA 2024; 9:44749-44759. [PMID: 39524626 PMCID: PMC11541793 DOI: 10.1021/acsomega.4c07459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/20/2024] [Revised: 10/02/2024] [Accepted: 10/11/2024] [Indexed: 11/16/2024]
Abstract
We established a university-community partnership with the Boys and Girls Clubs of Chicago (BGCC)-named Chicago Antibiotic Discovery Lab-to involve middle school students in antibiotic discovery research. In the course of working with a cohort of students from the BGCC, one student isolated a Pseudomonas idahonensis bacterium from a goose feces sample that produced a new cyclic lipodepsipeptide, which was characterized as orfamide N. Orfamide N is composed of ten mixed D/L-amino acids and a (Z)-3R-hydroxyhexadec-9-enoic acid residue. The planar structure of orfamide N was elucidated by one-dimensional (1D) and two-dimensional nuclear magnetic resonance (2D NMR), electrospray ionization-mass spectrometry (ESI-MS), and ozone-induced dissociation mass spectrometry (OzID-MS). The absolute configuration was determined by advanced Marfey's analysis, phylogenetic analysis of C-domains within the orfamide N biosynthetic gene cluster, and chiral high-performance liquid chromatography (HPLC) analysis of the hydrolyzed and reduced lipid tail. Orfamide N was cytotoxic against human melanoma and human ovarian cancer cells with IC50 values of 11.06 and 10.50 μM, respectively. Overall, we demonstrated it is possible to integrate educational outreach with high-end natural product discovery while strengthening the relationship between the university and the community it serves.
Collapse
Affiliation(s)
- Jin Yi Tan
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Mario Augustinović
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Ashraf M. Omar
- Center
for Translational Biomedical Research, University
of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
| | - Vitor B. Lourenzon
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Nyssa Krull
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Xochitl Lopez
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Manead Khin
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Gauri Shetye
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Duc Nguyen
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Mallique Qader
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Angela C. Nugent
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Enock Mpofu
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Camarria Williams
- Boys
and Girls Clubs of Chicago, Chicago, Illinois 60612, United States
| | | | - Joanna E. Burdette
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Sanghyun Cho
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Scott G. Franzblau
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
- Institute
for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Alessandra S. Eustáquio
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| | - Qibin Zhang
- Center
for Translational Biomedical Research, University
of North Carolina at Greensboro, Greensboro, North Carolina 27412, United States
| | - Brian T. Murphy
- Department
of Pharmaceutical Sciences, Center for Biomolecular Sciences, College
of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States
| |
Collapse
|
|
2
|
Kimishima A, Tsuruoka I, Tsutsumi H, Honsho M, Honma S, Matsui H, Sugamata M, Wasuwanich P, Inahashi Y, Hanaki H, Asami Y. A new tetronomycin analog, broad-spectrum and potent antibiotic against drug-resistant Gram-positive bacteria. Chem Biodivers 2024; 21:e202301834. [PMID: 38179845 DOI: 10.1002/cbdv.202301834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 01/04/2024] [Accepted: 01/04/2024] [Indexed: 01/06/2024]
Abstract
We discovered a new tetronomycin analog, C-32-OH tetronomycin (2) from the Streptomyces sp. K20-0247 strain, which produces tetronomycin (1). After NMR analysis of 2, we determined the planar structure. Futhermore, the absolute stereochemistry of 2 was deduced based on the biosynthetic pathway of 1 in the K20-0247 strain and a comparison of experimental electronic circular dichroism (ECD) results of 1 with 2. While 2 exihibits potent antibacterial activity aganist Gram-positive baceria including vancomycin-intermediate Staphylococcus aureus (VISA) strains and vancomycin-resistant Enterococci (VRE), the antibacterial activity of 2 shows 16-32-folds weaker than that of 1 suggesting that the C-34 methyl group in 1 is one of the very important functinal group. Moreover, we evaluated the ionophore activity of 1 and 2 and neither compound shows ionophore activity at reasonable concetrations. Our research suggests that 1 and 2 would have different target(s) from an ionophore mechanism in the antibacterial activity and tetronomycins are promising natural products for broad-spectrum antibiotics.
Collapse
Affiliation(s)
- Aoi Kimishima
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Iori Tsuruoka
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Hayama Tsutsumi
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Masako Honsho
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Sota Honma
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Hidehito Matsui
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Miho Sugamata
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Paul Wasuwanich
- University of Florida College of Medicine, Gainesville, FL 32610, USA
| | - Yuki Inahashi
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Hideaki Hanaki
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| | - Yukihiro Asami
- Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
- Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane Minato-ku, 108-8641, Tokyo, Japan
| |
Collapse
|